Expression of GLP-1R in Activated PSCs in the Pancreas of Rats with CP The possible expression of GLP-1R in activated PSCs in the CP model was investigated in more detail (Figure 5)
Although the gene of this neuropeptide and the exact mechanism of its action remain unknown, it has been found in free and bound form in the hypothalamus, limbic system and pituitary gland
Additionally, some study results also suggest that GLP-1 RAs reduce the occurrence of anxiety, depression, suicidal behaviors, and so on [Reference Tsai, Sung, Chiu, Shih, Tsai and Wu12, Reference Wang, Volkow, Berger, Davis, Kaelber and Xu49, Reference Pozzi, Mazhar, Peeters, Vantaggiato, Nobile, Clementi and Nobile50]
Clinical studies show that retatrutide could be the most powerful drug to be developed for the treatment of obesity
[10] The first amylin analogue to reach the clinic, pramlintide, demonstrated that the pathway could be drugged, but native-style amylin analogues are short-acting and were used as multiple-daily injections, which limited their appeal for weight management